Studies have demonstrated that OVs can inhibit the growth and distant metastasis of colorectal cancer cells by lysing CRC cells, inducing apoptosis, and reversing TME, and have shown exciting results in treating CRC peritoneal metastases and KRAS-mutated colorectal cancer. This evidence concerns the gene KRAS and colorectal carcinoma.